XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses        
Selling, general and administrative $ 114,567 $ 130,873 $ 438,583 $ 516,296
Research and development 152,667 27,566
Depreciation and amortization 160 479
Total operating expense 114,567 131,033 591,250 544,341
Loss from operations (114,567) (131,033) (591,250) (544,341)
Other income (expense):        
Interest expense (32,197) (100,681) (164,731) (313,830)
Finance charges (35,721) (173,118)
Gain on assignment of debt 603,204 3,332,280 711,896 3,332,280
Receipt of common shares 5,761,500 5,761,500
Change in market value of common shares (3,105,000) (3,105,000)
Gain (loss) on market value of derivative liability 1,029,570 1,178,230 197,008
Total other expense 3,227,507 4,225,448 4,381,895 3,042,340
Net income $ 3,112,940 $ 4,094,415 $ 3,790,645 $ 2,497,999
Basic income per share attributable to common stockholders $ 6.44 $ 8.95 $ 7.86 $ 5.46
Diluted income per share attributable to common stockholders $ 0.24 $ 0.24 $ 0.29 $ 0.17
Weighted average number of shares outstanding 483,714 457,578 482,527 457,578